Company / Net Income
Insulet Corporation Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$247.1M
FY2025
5-year range
$4.6M / $418.3M
FY2021-FY2025
Trend
-40.9%
vs FY2024
Sector context
#47 of 158
Health Care
What the data says
At $247M, Insulet Corporation's net income ranks #47 of 158 in the Health Care sector. Net Income has fluctuated over the past 10 years, ranging from -$29M in FY2016 to $418M in FY2024.
Based on SEC 10-K filings.
$247M in FY2025 with a 5-year CAGR of +105.2%.
Improved from $206M to $247M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- +277.3%
- 5-Year CAGR
- +105.2%
- 10-Year CAGR
- -
Sector benchmark
#47 of 158 in Health CareTop 30% of 158This company $247.1M Sector average $458.6M
▼
-46.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +105.2%, indicating consistent growth.
- In FY2025, net income decreased 40.9% year-over-year.
- Ranks #47 out of 158 companies in the Health Care sector.
- Peak net income was recorded in FY2024.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $247.1M | -40.9% |
| FY2024 | $418.3M | +102.8% |
| FY2023 | $206.3M | +4384.8% |
| FY2022 | $4.6M | -72.6% |
| FY2021 | $16.8M | +147.1% |
| FY2020 | $6.8M | -41.4% |
| FY2019 | $11.6M | +251.5% |
| FY2018 | $3.3M | +112.3% |
| FY2017 | -$26.8M | +7.2% |
| FY2016 | -$28.9M | +60.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026